MPG.eBooks - Search Results

Cover Image

1

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...

Published 2020

CADTH

Cover Image

2

CADTH Canadian Drug Expert Committee recommendation: Etonogestrel extended-release subdermal implant (Nexplanon -- Merck Canada Inc.) : indication : prevention of pregnancy for up...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

3

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

4

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

5

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion Pharmaceuticals Canada Inc.) : Indication: pulmonary arterial hypertension

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

6

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

7

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

8

CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

9

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...

Published 2018

CADTH

Cover Image

10

CADTH Canadian drug expert committee recommendation: Cabotegravir tablets, cabotegravir extended-release injectable suspension and rilpivirine extended-release injectable suspensio...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

11

CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

12

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

13

CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

14

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

15

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

16

CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

17

CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

18

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

19

CADTH Canadian drug expert committee recommendation: Siponimod (Mayzent -- Novartis Pharmaceuticals Canada Inc.) : indication : secondary progressive multiple sclerosis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

20

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

1
2
3
4
5
6
7
8